Optimi Health Corp. (FRA:8BN)

Revenue by Product

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Raw Mushroom Biomass, Mushroom Extracts and Mushroom Supplements	389.85K
Raw Mushroom Biomass, Mushroom Extracts and Mushroom Supplements Growth	115.28%

Revenue by Geography

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Canada	389.85K
Canada Growth	115.28%